Search Results 961-970 of 16340 for Ureaplasma urealyticum

1. Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery - Mayo Clinic

   Acute bacterial, viral, or fungal infection requiring treatment at the time of registration. Active infection or other serious underlying medical condition ...

2. Non-Hodgkin lymphoma - Diagnosis and treatment - Mayo Clinic

   Tests of your blood and urine may help rule out an infection or other disease. Imaging tests. Tests to look for lymphoma cells in other parts of the body may ...

3. A Study to Evaluate Itacitinib for Low Risk Graft-vs-Host Disease (GVHD) - Mayo Clinic

   Patients with uncontrolled infection (i.e., progressive symptoms related to infection despite treatment or persistently positive microbiological cultures ...

4. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

   Participation eligibility · Uncontrolled, active infection requiring intravenous antibiotics · New York Heart Association (NYHA) Class III or Class IV heart ...

5. Videos - Nucleic Acid Structure and Recognition: Jim Maher - Mayo Clinic Research

   Jim Maher, Ph.D., discusses paraganglioma and the Paradifference Foundation, which supports Mayo Clinic research through the generosity of the Gustavsson ...

6. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

   Has an active infection requiring systemic antibiotics; Has had surgery requiring general anesthesia within 4 weeks of starting the study; Has heart failure ...

7. Cutaneous T-cell lymphoma - Diagnosis and treatment - Mayo Clinic

   Your doctor may give you specific treatments to control itching and manage your infection risk. It may also help to: Use mild, unscented soap. Using a mild ...

8. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   Patients must not have been treated with antibiotics for an active infection within 14 days prior to registration. Prophylactic antibiotics are permitted ...

9. Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery - Mayo Clinic

   ... infection. Testing should be conducted to determine eligibility. Patients with a known history of testing positive for human immunodeficiency virus (HIV) or ...

10. Uterine microbe found to have disease-causing behavior in endometrial cancer - Mayo Clinic News Network

    A tiny microbe thriving in the uterine microbiome — a population of bacteria, viruses, yeasts/fungi in and around the uterus— could be a contributing driver ...